BBOT Leadership to Showcase Innovations at December Events
BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focusing on RAS-pathway malignancies, will be represented at two significant investor conferences this December. The leadership team's participation underscores BBOT's commitment to advancing innovative treatments for cancer.
Conference Details
Piper Sandler 37th Annual Healthcare Conference
BBOT's leadership will present at the Piper Sandler conference on Tuesday, December 2, at 2:00 p.m. ET. This event serves as a platform for investors to gain insights into the company's strategic direction and its innovative pipeline.
8th Annual Evercore Healthcare Conference
Additionally, BBOT will be featured at the 8th Annual Evercore Healthcare Conference, scheduled for Wednesday, December 3, at 9:35 a.m. ET. This conference will provide further opportunities for investors to learn about BBOT's advancements and its focus on RAS and PI3K? malignancies.
Live Webcasts and Replays
Investors and interested parties can access live webcasts of both presentations through BBOT's official website. Following the events, replays of the webcasts will be available for at least 90 days, ensuring that stakeholders can stay updated despite unable to attend live.
About BBOT
BBOT is committed to revolutionizing cancer treatment through an advanced pipeline of small molecule therapeutics. Aiming to improve patient outcomes, the company targets RAS and PI3K? malignancies, which are known to be among the most prevalent drivers of human tumors. With a focus on innovation and efficacy, BBOT continues to make strides in the biopharmaceutical landscape.
For more information about BBOT and its therapeutic advancements, interested individuals can visit the official BBOT website or follow the company on its social media platforms.
Contact Information
Investor Contact
For inquiries regarding investments, please reach out to: Heather Armstrong, BBOT. Email: Heather.Armstrong@bbotx.com
Media Contact
For media relations, please contact: Jake Robison at Inizio Evoke Comms. Email: Jake.robison@inizioevoke.com
Frequently Asked Questions
What is BBOT focusing on in its upcoming presentations?
In the upcoming presentations, BBOT will focus on its innovative treatments targeting RAS and PI3K? malignancies.
When are the BBOT presentations scheduled?
BBOT's presentations are scheduled for December 2 at 2:00 p.m. ET and December 3 at 9:35 a.m. ET.
How can I access BBOT's live presentations?
Live webcasts of the presentations will be accessible on the BBOT website's events page.
What will happen after the live presentations?
The presentations will be available for replay on the BBOT website for at least 90 days following the events.
Who can I contact for more information about BBOT?
For inquiries, you can contact Heather Armstrong for investor relations and Jake Robison for media relations.
